IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Design and Development of Indian Propolis Loaded Poly (e -Caprolactone) Nanoparticles For Improved Anticancer Efficacy

Author: DR. SATHIYANARAYANAN LOHIDASAN, HARSHAD KAPARE , ARULMOZHI S , KAKASAHEB MAHADIK
Abstract: Propolis, a natural product obtained from apiculture and is well proven for its anticancer potential. Anticancer efficacy of propolis is limited to its poor water solubility and bioavailability. The present study was designed and investigated for development of ethanolic extract of Indian propolis (EEIP) loaded Poly (e-caprolactone) nanoparticles (EPL) to achieve improved solubility, sustained drug release and enhanced cytotoxic efficacy of EEIP. Formulation development, characterization and optimization were carried out by design of experiment approach. Developed formulations were evaluated in detail for nanoparticle characterization and in vitro cytotoxicity study. Developed nanoparticles showed particle size, and encapsulation efficiency of 190 ± 1 - 230 ± 2 nm and 62.66± 1.20 - 67.18± 1.80 % respectively. Optimized formulation EPL showed sustained drug release over a period of 48 h. Concentration of the drug needed for total growth inhibition of cells in a designed time period (TGI) was decreased by 33.06% for EPL as compared to EEIP in human breast cancer MCF-7 cells and 22.31% in human colon cancer cells HT-29 indicating improved cytotoxicity of EEIP. The study proven that the optimized EPL exhibited increased solubility, sustained drug release and enhanced in vitro cytotoxicity on MCF-7 and HT-29 cell lines in comparison with EEIP. Thus developed system may be served as potential nanocarrier in anticancer treatment.
Keyword: Indian propolis; Poly (e-caprolactone); Design of experiment; Sulforhodamine B (SRB) assay
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free